Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 7, 2020; 26(1): 55-69
Published online Jan 7, 2020. doi: 10.3748/wjg.v26.i1.55
Published online Jan 7, 2020. doi: 10.3748/wjg.v26.i1.55
Figure 4 Astragalus polysaccharides combined with matrine inhibit the expression of zonula occludens-1 and Occludin in lung and colon tissues of rats with ulcerative colitis.
A and B: Zonula occludens-1 (ZO-1) expression in colon (A) and lung tissues (B) in various groups detected by Western blot analysis; C and D: Occludin expression in colon (C) and lung tissues (D) in various groups detected by immunohistochemistry analysis. aP < 0.05 and bP < 0.01 vs normal group; cP < 0.05 and dP < 0.01 vs model group. APS: Astragalus polysaccharides; ZO-1: Zonula occludens-1; N: Normal group; M: Model group; SC: Salazopyrine control group; MT: Matrine treatment group; AT: Astragalus polysaccharides treatment group; MM: Monomer mixture group.
- Citation: Yan X, Lu QG, Zeng L, Li XH, Liu Y, Du XF, Bai GM. Synergistic protection of astragalus polysaccharides and matrine against ulcerative colitis and associated lung injury in rats. World J Gastroenterol 2020; 26(1): 55-69
- URL: https://www.wjgnet.com/1007-9327/full/v26/i1/55.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i1.55